Creatine and/or creatinine compositions and related methods
AssigneeThermoLife International, LLC
InventorsAlexandros Nikolaidis, Ronald Kramer
Life of this patent
Estimating the term…
Abstract
The disclosure is directed to methods related to creatinine, for example, a method for its safe administration to a human, a method for using creatinine to improve the bioavailability of creatine, and a metn.
Claims19
A method of improving the oral bioavailability of creatine, the method comprising co-administering to a human subject an effective amount of creatine, creatinine, and nitrate (NO3−), wherein the effective amount of creatine is at least about 500 mg, the effective amount of creatinine is at least about 500 mg, and the effective amount of nitrate (NO3−) is at least about 50 mg nitrate (NO3−).
A method of improving the oral bioavailability of creatine, the method comprising co-administering to a human subject an effective amount of creatine, creatinine, and nitrate (NO3−), wherein the molar ratio of the amount of nitrate (NO3−) to the amount of creatinine is between about 20:1 and about 1:9.
A method of improving the oral bioavailability of creatine, the method comprising administering to a human subject a composition comprising an effective amount of creatine and creatinine, wherein the molar ratio of the effective amount of creatine and creatinine is 1:1 to 1:1.7 and the pH of the composition is 4.2 to 4.4.
Dependencies are inferred from the claim text.